A detailed history of Loomis Sayles & CO L P transactions in Icon PLC stock. As of the latest transaction made, Loomis Sayles & CO L P holds 66,901 shares of ICLR stock, worth $13.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
66,901
Previous 67,127 0.34%
Holding current value
$13.9 Million
Previous $21 Million 8.65%
% of portfolio
0.03%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$280.48 - $346.2 $63,388 - $78,241
-226 Reduced 0.34%
66,901 $19.2 Million
Q2 2024

Aug 13, 2024

SELL
$288.23 - $331.73 $2.88 Million - $3.31 Million
-9,991 Reduced 12.96%
67,127 $21 Million
Q1 2024

May 14, 2024

SELL
$247.84 - $340.0 $287,742 - $394,740
-1,161 Reduced 1.48%
77,118 $25.9 Million
Q4 2023

Feb 13, 2024

SELL
$222.83 - $285.76 $530,335 - $680,108
-2,380 Reduced 2.95%
78,279 $22.2 Million
Q3 2023

Nov 09, 2023

SELL
$236.44 - $265.62 $1.55 Million - $1.75 Million
-6,575 Reduced 7.54%
80,659 $19.9 Million
Q2 2023

Aug 11, 2023

SELL
$183.12 - $250.2 $268,087 - $366,292
-1,464 Reduced 1.65%
87,234 $21.8 Million
Q1 2023

May 11, 2023

SELL
$193.59 - $245.33 $1.4 Million - $1.77 Million
-7,227 Reduced 7.53%
88,698 $18.9 Million
Q4 2022

Feb 10, 2023

SELL
$173.9 - $224.8 $140,685 - $181,863
-809 Reduced 0.84%
95,925 $18.6 Million
Q3 2022

Nov 14, 2022

SELL
$183.25 - $247.5 $1.35 Million - $1.82 Million
-7,353 Reduced 7.06%
96,734 $17.8 Million
Q2 2022

Aug 05, 2022

SELL
$197.3 - $261.32 $25.9 Million - $34.3 Million
-131,318 Reduced 55.78%
104,087 $22.6 Million
Q1 2022

May 13, 2022

BUY
$216.09 - $296.03 $207,662 - $284,484
961 Added 0.41%
235,405 $57.3 Million
Q4 2021

Feb 14, 2022

SELL
$258.11 - $309.7 $651,985 - $782,302
-2,526 Reduced 1.07%
234,444 $72.6 Million
Q3 2021

Nov 12, 2021

BUY
$208.53 - $283.04 $8.3 Million - $11.3 Million
39,791 Added 20.18%
236,970 $62.1 Million
Q2 2021

Aug 13, 2021

SELL
$194.07 - $232.2 $4.33 Million - $5.18 Million
-22,299 Reduced 10.16%
197,179 $40.8 Million
Q1 2021

May 17, 2021

SELL
$171.87 - $220.96 $570,608 - $733,587
-3,320 Reduced 1.49%
219,478 $43.1 Million
Q4 2020

Feb 12, 2021

SELL
$180.3 - $214.08 $421,541 - $500,519
-2,338 Reduced 1.04%
222,798 $43.4 Million
Q3 2020

Nov 12, 2020

SELL
$166.91 - $196.1 $8 Million - $9.39 Million
-47,908 Reduced 17.55%
225,136 $43 Million
Q2 2020

Aug 14, 2020

BUY
$129.79 - $170.94 $606,119 - $798,289
4,670 Added 1.74%
273,044 $46 Million
Q1 2020

May 15, 2020

SELL
$115.95 - $177.22 $670,770 - $1.03 Million
-5,785 Reduced 2.11%
268,374 $36.5 Million
Q4 2019

Feb 14, 2020

SELL
$139.48 - $172.23 $2.58 Million - $3.19 Million
-18,514 Reduced 6.33%
274,159 $47.2 Million
Q3 2019

Nov 13, 2019

BUY
$146.89 - $161.41 $4.52 Million - $4.97 Million
30,786 Added 11.76%
292,673 $43.1 Million
Q2 2019

Aug 14, 2019

BUY
$129.99 - $153.97 $1.75 Million - $2.07 Million
13,468 Added 5.42%
261,887 $40.3 Million
Q1 2019

May 15, 2019

SELL
$121.3 - $146.95 $602,739 - $730,194
-4,969 Reduced 1.96%
248,419 $33.9 Million
Q4 2018

Feb 14, 2019

BUY
$119.37 - $153.29 $1.78 Million - $2.28 Million
14,899 Added 6.25%
253,388 $32.7 Million
Q3 2018

Nov 13, 2018

SELL
$131.3 - $153.75 $1.62 Million - $1.89 Million
-12,318 Reduced 4.91%
238,489 $36.7 Million
Q2 2018

Aug 14, 2018

SELL
$111.38 - $137.03 $699,911 - $861,096
-6,284 Reduced 2.44%
250,807 $33.2 Million
Q1 2018

May 11, 2018

SELL
$103.82 - $123.9 $3.43 Million - $4.09 Million
-32,994 Reduced 11.37%
257,091 $30.4 Million
Q4 2017

Feb 14, 2018

BUY
$111.14 - $123.05 $1.79 Million - $1.98 Million
16,062 Added 5.86%
290,085 $32.5 Million
Q3 2017

Nov 14, 2017

SELL
$101.4 - $116.62 $1.98 Million - $2.27 Million
-19,483 Reduced 6.64%
274,023 $31.2 Million
Q2 2017

Aug 14, 2017

BUY
N/A
293,506
293,506 $28.7 Million

Others Institutions Holding ICLR

About ICON PLC


  • Ticker ICLR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 81,526,600
  • Market Cap $16.9B
  • Description
  • ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development proces...
More about ICLR
Track This Portfolio

Track Loomis Sayles & CO L P Portfolio

Follow Loomis Sayles & CO L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.